Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 3

Results: 22

Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.

Published in:

2023

By:

Xu, Dafeng;
Wang, Yu;
Chen, Yonghai;
Zheng, Jinfang

Publication type:

Correction Notice

Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 743, doi. 10.1007/s00262-022-03305-2

By:

Yin, Lili;
Wang, Yu

Publication type:

Article

Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 697, doi. 10.1007/s00262-022-03272-8

By:

Adams, Alexandra M.;
Carpenter, Elizabeth L.;
Clifton, Guy T.;
Vreeland, Timothy J.;
Chick, Robert C.;
O'Shea, Anne E.;
McCarthy, Patrick M.;
Kemp Bohan, Phillip M.;
Hickerson, Annelies T.;
Valdera, Franklin A.;
Tiwari, Ankur;
Hale, Diane F.;
Hyngstrom, John R.;
Berger, Adam C.;
Jakub, James W.;
Sussman, Jeffrey J.;
Shaheen, Montaser F.;
Yu, Xianzhong;
Wagner, Thomas E.;
Faries, Mark B.

Publication type:

Article

Detecting monocyte trafficking in an animal model of glioblastoma using R<sub>2</sub>* and quantitative susceptibility mapping.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 733, doi. 10.1007/s00262-022-03297-z

By:

Yang, Runze;
Hamilton, A. Max;
Sun, Hongfu;
Rawji, Khalil S.;
Sarkar, Susobhan;
Mirzaei, Reza;
Pike, G. Bruce;
Yong, V. Wee.;
Dunn, Jeff F.

Publication type:

Article

TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 769, doi. 10.1007/s00262-022-03275-5

By:

Li, Shance;
Zhang, Chaoting;
Shen, Luyan;
Teng, Xia;
Xiao, Yefei;
Yu, Bentong;
Lu, Zheming

Publication type:

Article

Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study

Published in:

2023

By:

Li, Chongwu;
Wu, Junqi;
Jiang, Long;
Zhang, Lei;
Huang, Jia;
Tian, Yu;
Zhao, Yue;
Liu, Xiucheng;
Xia, Lang;
E, Haoran;
Gao, Peigen;
Hou, Likun;
Yang, Minglei;
Ma, Minjie;
Su, Chunxia;
Zhang, Hao;
Chen, Hezhong;
She, Yunlang;
Xie, Dong;
Luo, Qingquan

Publication type:

Correction Notice

Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 707, doi. 10.1007/s00262-022-03284-4

By:

Azoulay, Tehila;
Slouzky, Ilana;
Karmona, Michal;
Filatov, Margarita;
Hayun, Michal;
Ofran, Yishai;
Sarig, Galit;
Ringelstein-Harlev, Shimrit

Publication type:

Article

PD-1<sup>+</sup> mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 633, doi. 10.1007/s00262-022-03282-6

By:

Li, Jun;
Peng, Gang;
Zhu, Kuikui;
Jie, Xiaohua;
Xu, Yingzhuo;
Rao, Xinrui;
Xu, Yunhong;
Chen, Yunshang;
Xing, Biyuan;
Wu, Gang;
Shi, Liangliang

Publication type:

Article

Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 591, doi. 10.1007/s00262-022-03281-7

By:

Sawa, Kenji;
Sato, Izumi;
Takeuchi, Masato;
Kawakami, Koji

Publication type:

Article

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 617, doi. 10.1007/s00262-022-03280-8

By:

Wu, Peng;
Zhang, Zhihui;
Yang, Zhaoyang;
Zhang, Chaoqi;
Luo, Yuejun;
Zhang, Guochao;
Wang, Lide;
Xue, Qi;
Sun, Nan;
He, Jie

Publication type:

Article

Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 599, doi. 10.1007/s00262-022-03279-1

By:

Liu, Zaoqu;
Xu, Hui;
Weng, Siyuan;
Guo, Chunguang;
Dang, Qin;
Zhang, Yuyuan;
Ren, Yuqing;
Liu, Long;
Wang, Libo;
Ge, Xiaoyong;
Xing, Zhe;
Zhang, Jian;
Luo, Peng;
Han, Xinwei

Publication type:

Article

Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 679, doi. 10.1007/s00262-022-03278-2

By:

Mao, Xiaofan;
Zhou, Dan;
Lin, Kairong;
Zhang, Beiying;
Gao, Juntao;
Ling, Fei;
Zhu, Lewei;
Yu, Sifei;
Chen, Peixian;
Zhang, Chuling;
Zhang, Chunguo;
Ye, Guolin;
Fong, Simon;
Chen, Guoqiang;
Luo, Wei

Publication type:

Article

Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 667, doi. 10.1007/s00262-022-03277-3

By:

Rydberg Millrud, Camilla;
Deronic, Adnan;
Grönberg, Caitríona;
Jaensson Gyllenbäck, Elin;
von Wachenfeldt, Karin;
Forsberg, Göran;
Liberg, David

Publication type:

Article

PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 719, doi. 10.1007/s00262-022-03276-4

By:

Hu, Xin;
Shui, Yifang;
Hirano, Hiroshi;
Kusano, Kisato;
Guo, Wen-Zhi;
Fujino, Masayuki;
Li, Xiao-Kang

Publication type:

Article

Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 561, doi. 10.1007/s00262-022-03270-w

By:

Dora, David;
Rivard, Christopher;
Yu, Hui;
Pickard, Shivaun Lueke;
Laszlo, Viktoria;
Harko, Tunde;
Megyesfalvi, Zsolt;
Gerdan, Csongor;
Dinya, Elek;
Hoetzenecker, Konrad;
Hirsch, Fred R.;
Lohinai, Zoltan;
Dome, Balazs

Publication type:

Article

Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 775, doi. 10.1007/s00262-022-03274-6

By:

Sonpavde, Guru P.;
Maughan, Benjamin Louis;
McGregor, Bradley Alexander;
Wei, Xiao X.;
Kilbridge, Kerry L.;
Lee, Richard J.;
Yu, Evan Y.;
Schweizer, Michael Thomas;
Montgomery, Robert B.;
Cheng, Heather H.;
Hsieh, Andrew Caleb;
Jain, Rohit;
Grewal, Jaspreet S.;
Pico-Navarro, Cesar;
Gafoor, Zarina;
Perschy, Teresa;
Grivas, Petros

Publication type:

Article

Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 579, doi. 10.1007/s00262-022-03271-9

By:

Laheurte, Caroline;
Seffar, Evan;
Gravelin, Eléonore;
Lecuelle, Julie;
Renaudin, Adeline;
Boullerot, Laura;
Malfroy, Marine;
Marguier, Amélie;
Lecoester, Benoit;
Gaugler, Béatrice;
Saas, Philippe;
Truntzer, Caroline;
Ghiringhelli, Francois;
Adotevi, Olivier

Publication type:

Article

Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 647, doi. 10.1007/s00262-022-03269-3

By:

Xu, Dafeng;
Wang, Yu;
Chen, Yonghai;
Zheng, Jinfang

Publication type:

Article

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 543, doi. 10.1007/s00262-022-03268-4

By:

Stavrou, Victoria;
Fultang, Livingstone;
Booth, Sarah;
De Simone, Daniele;
Bartnik, Arekdiusz;
Scarpa, Ugo;
Gneo, Luciana;
Panetti, Silvia;
Potluri, Sandeep;
Almowaled, Meaad;
Barlow, Jonathan;
Jankevics, Andris;
Lloyd, Gavin;
Southam, Andrew;
Priestman, David A.;
Cheng, Paul;
Dunn, Warwick;
Platt, Frances;
Endou, Hitoshi;
Craddock, Charles

Publication type:

Article

The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 783, doi. 10.1007/s00262-022-03262-w

By:

Li, Chongwu;
Wu, Junqi;
Jiang, Long;
Zhang, Lei;
Huang, Jia;
Tian, Yu;
Zhao, Yue;
Liu, Xiucheng;
Xia, Lang;
E, Haoran;
Gao, Peigen;
Hou, Likun;
Yang, Minglei;
Ma, Minjie;
Su, Chunxia;
Zhang, Hao;
Chen, Hezhong;
She, Yunlang;
Xie, Dong;
Luo, Qingquan

Publication type:

Article

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 759, doi. 10.1007/s00262-022-03250-0

By:

Rijnders, Maud;
Robbrecht, Debbie G. J.;
Oostvogels, Astrid A. M.;
van Brakel, Mandy;
Boormans, Joost L.;
Aarts, Maureen J. B.;
Balcioglu, Hayri E.;
Hamberg, Paul;
Voortman, Jens;
Westgeest, Hans M.;
Lolkema, Martijn P.;
de Wit, Ronald;
van der Veldt, Astrid A. M.;
Debets, Reno

Publication type:

Article

Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 527, doi. 10.1007/s00262-022-03248-8

By:

Ralph, Stephen John;
Reynolds, Maxwell J.

Publication type:

Article